Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Prev Vet Med ; 181: 105052, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32559557

RESUMEN

Antibiotics in aquaculture are used to treat bacterial infections. In order for these products to work effectively fish need to be properly dosed. One of the emerging issues in aquaculture is under-dosing large populations of fish with antibiotics. This happens inadvertently for a number of reasons including the use of fraudulent medications. In this study we evaluated 17 antibiotic products (8 florfenicol and 9 oxytetracycline brands purchased in Asia) by HPLC to determine if the product labels accurately reflected the active pharmaceutical ingredient (API) in the package. We determined authenticity scores for different batches of products at two separate laboratories by comparing the observed API to the label API concentration. We found that 48 % of the antibiotic batches had authenticity scores below 80 % (i.e. observed API in package was at least 20 % less than the label API concentration). Further, there were 9 or the 31 batches of drugs tested had no measureable API. Some products had variation in their authenticity scores between batches making it difficult to rely on a brand. The price of florfenicol products may help identify products with low authenticity scores, but in the case of oxytetracycline, the price of all the products tested was relatively similar. The findings in this study suggest that not all florfenicol and oxytetracycline antibiotic products on the market in Asia have API concentrations indicated on their labels. This could be problematic for medicating fish on aquaculture farms.


Asunto(s)
Antibacterianos/análisis , Acuicultura , Medicamentos Falsificados/análisis , Composición de Medicamentos/veterinaria , Fraude/estadística & datos numéricos , Oxitetraciclina/análisis , Tianfenicol/análogos & derivados , Antibacterianos/normas , Composición de Medicamentos/normas , Composición de Medicamentos/estadística & datos numéricos , Oxitetraciclina/normas , Tianfenicol/análisis , Tianfenicol/normas
2.
PLoS One ; 10(4): e0124267, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25897517

RESUMEN

Antimicrobial usage is common in Asian aquaculture. This study aimed to determine the quality of antimicrobial products used by Vietnamese striped catfish (Pangasianodon hypophthalmus) farmers. Twenty one antimicrobial products (11 products contained a single antimicrobial and 10 products contained a mixture of two different antimicrobials) commonly used by catfish farmers were obtained from so-called chemical shops located in the Mekong Delta, Vietnam. Ultra High Performance Liquid Chromatography Mass Spectrometry was used to analyze concentration of sulfonamides, trimethoprim, amoxicillin, cefalexin and ciprofloxacin whereas concentrations of florfenicol and doxycycline were analyzed by High Performance Liquid Chromatography with UV detection. Results revealed that only 4/11 products with a single antimicrobial and 2/10 products with a mixture of antimicrobials contained active substances within ±10% of the concentration declared on the product label. Two products with antimicrobial mixtures did not contain any of the declared antimicrobials. Comparing two batches, analysis of 11 products revealed that only one product contained a concentration of active compound that varied with less than 10% in both batches. Several product labels provided inadequate information on how to calculate therapeutic dosage and further stated withdrawal time despite lack of pharmacokinetic data on the antimicrobials in catfish. There is an urgent need to strengthen approval procedures and in particular regularly to monitor the quality of antimicrobials used in Vietnamese aquaculture.


Asunto(s)
Antiinfecciosos/análisis , Bagres , Drogas Veterinarias/análisis , Amoxicilina/análisis , Amoxicilina/normas , Animales , Antiinfecciosos/normas , Acuicultura , Cefalexina/análisis , Cefalexina/normas , Ciprofloxacina/análisis , Ciprofloxacina/normas , Doxiciclina/análisis , Doxiciclina/normas , Control de Calidad , Estándares de Referencia , Sulfonamidas/análisis , Sulfonamidas/normas , Tianfenicol/análogos & derivados , Tianfenicol/análisis , Tianfenicol/normas , Trimetoprim/análisis , Trimetoprim/normas , Drogas Veterinarias/normas , Vietnam
3.
Am J Vet Res ; 60(8): 960-4, 1999 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10451205

RESUMEN

OBJECTIVE: To evaluate efficacy of florfenicol in an induced model of infectious bovine keratoconjunctivitis, using a blinded randomized, controlled trial. ANIMALS: 48 male Holstein calves, 2 to 4 months old. PROCEDURE: Moraxella bovis infection was induced in all calves. When corneal ulcers developed, each calf was assigned randomly to 1 of 3 treatment groups, using a block design determined by corneal ulcer size (day 0). Calves were treated with florfenicol (20 mg/kg of body weight, IM) on days 0 and 2 (IM group; n = 16). Calves of a second group received a single dose of florfenicol (40 mg/kg, SC) on day 0 (SC group; n = 16). The third group of calves was not treated (control group; n = 16). Corneal ulcers were photographed, and each calf was assessed for 30 days after treatment for 10 clinical signs of infection. Corneal ulcer surface areas were measured, and clinical scores were calculated. Ocular secretions for microbiologic culture were obtained weekly from each eye. RESULTS: A Cox regression model indicated that, after adjustment for initial ulcer size, healing rates were 6.2 and 4.8 times greater in calves of the IM and SC groups, respectively, compared with the control group. Clinical scores and surface area measurements for treatment groups were significantly smaller than those for controls during posttreatment weeks 1 through 4. From day 8 through day 29, M bovis was isolated from ocular secretions of 14 of 16 control calves and 1 of 32 treated calves. CONCLUSIONS AND CLINICAL RELEVANCE: Parenterally administered florfenicol reduces corneal ulcer healing time, lessens clinical severity, and reduces the amount of bacterial shedding from calves infected with M bovis.


Asunto(s)
Antibacterianos/normas , Enfermedades de los Bovinos/tratamiento farmacológico , Queratoconjuntivitis Infecciosa/tratamiento farmacológico , Moraxella bovis , Infecciones por Neisseriaceae/veterinaria , Tianfenicol/análogos & derivados , Animales , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Bovinos , Medios de Contraste/química , Úlcera de la Córnea/tratamiento farmacológico , Fluoresceína/química , Inyecciones Intramusculares/veterinaria , Inyecciones Subcutáneas/veterinaria , Masculino , Moraxella bovis/efectos de los fármacos , Infecciones por Neisseriaceae/tratamiento farmacológico , Fotograbar/veterinaria , Modelos de Riesgos Proporcionales , Tianfenicol/administración & dosificación , Tianfenicol/normas , Tianfenicol/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...